Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kondo, Y.
Right arrow Articles by Imura, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kondo, Y.
Right arrow Articles by Imura, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 20, No. 8, 1625-1628, August 1999
© 1999 Oxford University Press


Short Communications

Metallothionein modulates the carcinogenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine in mice

Yukihiro Kondo, Seiichiro Himeno1, Wakako Endo1, Masaharu Mita1, Yasutomo Suzuki, Kaoru Nemoto, Masao Akimoto, John S. Lazo2 and Nobumasa Imura1,3

Department of Urology, Nippon Medical School, Bunkyo-ku, Tokyo 113-8603,
1 Department of Public Health and Molecular Toxicology, School of Pharmaceutical Sciences, Kitasato University, Minato-ku, Tokyo 108-8641, Japan and
2 Department of Pharmacology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA

We examined the carcinogenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) in transgenic mice deficient in the metallothionein (MT) I and II genes and in control (129/Sv) mice. Both strains of mice were given BBN for 8 weeks with or without Zn treatment. All mice were killed at 12 weeks after the cessation of BBN administration. BBN induced bladder tumors in 75% of MT null mice and in 43% of 129/Sv mice. The average number of bladder tumors per mouse was significantly higher in MT null mice (1.18 ± 0.27) than in 129/Sv mice (0.43 ± 0.20). Zn treatment suppressed the carcinogenicity of BBN in 129/Sv mice but not in MT null mice. Histopathological examination of the tumors revealed that the malignant potential of bladder tumors in 129/Sv mice was greater than that in MT null mice. These results indicate that MT is an important modulator of carcinogenicity of BBN in the bladder of mice.

Abbreviations: BBN, N-butyl-N-(4-hydroxybutyl)nitrosamine; DMBA, 7,12-dimethylbenz[a]anthracene; MT, metallothionein.

3 To whom correspondence should be addressed. Email: imuran{at}mc2.pharm.kitasato-u.ac.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H. G. Jeong, C.-K. Youn, H.-J. Cho, S.-H. Kim, M.-H. Kim, H.-B. Kim, I.-Y. Chang, Y.-S. Lee, M.-H. Chung, and H. J. You
Metallothionein-III Prevents {gamma}-Ray-induced 8-Oxoguanine Accumulation in Normal and hOGG1-depleted Cells
J. Biol. Chem., August 13, 2004; 279(33): 34138 - 34149.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. S. Suzuki, N. Nishimura, B. Zhang, Y. Nakatsuru, S. Kobayashi, M. Satoh, and C. Tohyama
Metallothionein deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice
Carcinogenesis, June 1, 2003; 24(6): 1123 - 1132.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. Greenwald, J. A. Milner, and C. K. Clifford
Creating a New Paradigm in Nutrition Research within the National Cancer Institute
J. Nutr., December 1, 2000; 130(12): 3103 - 3105.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.